DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 34 · November 2001 DOI: 10.1055/s-002-1233

Mitteilungen

  • 1
    Modell, S.; Holsboer, F.:

    Mitteilungen der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)

    • Original Paper

  • 217
    Vormfelde, S. V.; Poser, W.:

    Death Attributed to Methadone

  • 223
    Baptista, T.; Lacruz, A.; Angeles, F.; Silvera, R.; de Mendoza, S.; Mendoza, M. T.; Hernández, L.:

    Endocrine and Metabolic Abnormalities Involved in Obesity Associated with Typical Antipsychotic Drug Administration

  • 232
    Tsutsumi, T.; Akiyoshi, J.; Hikichi, T.; Kiyota, A.; Kohno, Y.; Katsuragi, S.; Yamamoto, Y.; Isogawa, K.; Nagayama, H.:

    Suppression of Conditioned Fear by Administration of CCKB Receptor Antisense Oligodeoxynucleotide into the Lateral Ventricle

  • 238
    Lam, L. C. W.; Garcia-Barcelo, M. M.; Ungvari, G. S.; Tang, W. K.; Lam, V. K. L.; Kwong, S. L.; Lau, B. S. T.; Kwong, P. P. K.; Waye, M. M. Y.; Chiu, H. F. K.:

    Cytochrome P450 2D6 Genotyping and Association with Tardive Dyskinesia in Chinese Schizophrenic Patients

    • Review

  • 242
    Dietrich, D. E.; Kropp, S.; Emrich, H. M.:

    Oxcarbazepine in Affective and Schizoaffective Disorders

    • Short Communication

  • 251
    Braus, D. F.; Ende, G.; Weber-Fahr, W.; Demirakca, T.; Henn, F. A.:

    Favorable Effect on Neuronal Viability in the Anterior Cingulate Gyrus due to Long-Term Treatment with Atypical Antipsychotics: An MRSI Study

    • Case Report

  • 254
    Kaschka, W. P.; Meyer, A.; Schier, K. R.; Fröscher, W.:

    Treatment of Pathological Crying with Citalopram

  • 259
    Pedrosa Gil, F.; Grohmann, R.; Rüther, E.:

    Asymptomatic Bradycardia Associated with Amisulpride

    • Letter to the Editor

  • 262
    Dose, M.:

    Neuroleptic-Induced Pseudo-Catatonia

    • Letter to the editor

  • 263
    Deuschle, M.:

    Reply by the authors

  • 264
    Hesslinger, B.; Walden, J.; Normann, C.:

    Reply from the authors